microfluidics Bioké Inks Distribution Agreements With Scale Biosciences, Atrandi Biosciences The deals add to the Dutch distributor's single-cell sequencing and microfluidics technology offerings in the Netherlands, Belgium, and Luxembourg. European 3DSecret Project to Deliver New Microfluidic Platform to Predict Cancer Metastasis Premium Sphere Fluidics is the sole commercial partner and has the right to commercialize any resulting technology. Angle, BioView Partner to Develop Quantitative HER2 Assay Using Circulating Tumor Cells The companies said recent developments in HER2-targeted therapies have created new commercial opportunities for a blood-based test. Samplix Garners €10M in Funding From European Innovation Council Copenhagen-based Samplix will use the accelerator investment to develop approaches for the functional characterization of single cells. Atrandi Biosciences Raises $4.8M to Advance Commercialization of Single-Cell Microfluidics Tech The company, formerly called Droplet Genomics, will apply the funds to establish a US customer support team and to advance commercialization of its droplet-based platforms. Mar 23, 2023 Irish Diagnostics Firm Altratech Aims to Enter Molecular, POC Testing Space by Supplanting PCR Premium Mar 16, 2023 Integra Biosciences Acquires Miroculus Feb 24, 2023 New Droplet-Based Single-Cell RNA-Seq Method Enables Transcriptome Profiling of Individual Synapses Premium Dec 16, 2022 KU Leuven-led Project Aims to Develop Mass PCR Testing Platform for Future Pandemics Premium Dec 8, 2022 New Standard BioTools Management Counting on Better Business Processes to Turn Firm Around Premium Nov 18, 2022 UCLA Team Uses Magnets, Microfluidics to Create Handheld Molecular Dx System Premium Oct 13, 2022 Standard BioTools Partner Ascendas Genomics Gets Chinese Approval for MDx Systems Jun 17, 2022 EUA in Hand, MicroGEM Aims to Grow Market for 30-Minute RT-PCR System Premium May 11, 2022 Interpace Biosciences, Miroculus, Twist Bioscience Partner to Automate NGS Library Prep in Cancer Dx May 5, 2022 Standard BioTools Q1 Revenues Fall 19 Percent Mar 24, 2022 Volta Labs, Miroculus Independently Harness Electrowetting for Automated NGS Sample Prep Premium Mar 17, 2022 Volta Labs Raises $20M in Series A Financing Round Jan 25, 2022 Droplet Genomics Debuts New Microfluidic Screening Platform, Touting Throughput, Flexibility Premium Jan 13, 2022 Florida Atlantic University Wins $1.3M NIH Grant to Develop Sample-to-Answer HIV Self-Test Dec 16, 2021 Single-Cell Startup Nodexus Raises $30M in Series A Financing Round Dec 14, 2021 Sphere Fluidics Plans New Applications for Single-Cell Isolation, Assay Platform Premium Oct 29, 2021 Qiagen, NeuMoDx Lose Patent Appeal in BD/HandyLab Dispute Oct 7, 2021 Angle Readies for Clinical Testing as CTC Research Continues to Yield Biomarker Insights Premium Aug 26, 2021 Scienion, Cellenion Enter Exclusive Licensing Deal, Partnership With Pacific Northwest National Lab Jul 28, 2021 Capio Biosciences, BioView to Explore Integration of Circulating Tumor Cell Technologies Load More Breaking News Compact Gene Editing Enzyme May Improve Success Rates of Gene Therapies People in the News at Veracyte, Invitae, Mount Sinai, InterVenn Biosciences, Applied BioCode, More New Products Posted to GenomeWeb: Qiagen, IDT, Revvity, Mission Bio, NRichDx, More FDA Releases Proposed Rule for Oversight of Laboratory-Developed Tests CStone Pharmaceuticals, Genetron Companion Diagnostic Receives NMPA Approval The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.